Heatwurx (PCSA)
(Delayed Data from NSDQ)
$2.15 USD
-0.28 (-11.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.07 -0.08 (-3.72%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth NA Momentum NA VGM
Heatwurx Inc. (PCSA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.00 | $4.00 | $4.00 | 64.61% |
Price Target
Only one analyst offered a short-term price target of $4.00 for Heatwurx Inc. This represents an increase of 64.61% from the last closing price of $2.43.
Analyst Price Targets (1 )
Broker Rating
Heatwurx Inc. currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on two recommendations.
Of the three recommendations deriving the current ABR, two are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/25/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Not Available | Strong Buy |
3/6/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Strong Buy |
11/17/2023 | Maxim Group | Naz Rahman | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 3 |
Average Target Price | $6.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | -1.18 |